Urban Moonshine

Digestive Bitters Chamomile

F
N+ Score25
Vitamins & MineralsServing: 0.25 tspType: Botanical

Urban Moonshine's Digestive Bitters Chamomile is a botanical supplement, falling under the Vitamins & Minerals category, formulated to support digestion. This product received an N+ Score of 25, which translates to an F grade and a 'poor' tier rating. The formulation features a "Proprietary Blend (Combination)" as its sole active ingredient, without disclosing the specific herbs or their individual dosages within the 0.25 tsp serving. This lack of transparency is a major concern, as it prevents consumers from verifying if any ingredients are present at clinically effective levels. Individuals seeking clear, evidence-based digestive support with known ingredient quantities may find this product's formulation opaque. Its broad approach may appeal to those exploring traditional bitter formulations without specific dosage expectations.

About This Product

Digestive Bitters Chamomile by Urban Moonshine is a vitamins & minerals supplement containing 1 active ingredients. It has earned an N+ Score of 25/100 (Grade F).

N+ Score Breakdown

Ingredient Adequacy50/100

Are key ingredients present at clinically effective doses based on research?

Formula Completeness0/100

Does the product include all expected ingredients for its supplement category?

Label Transparency0/100

Are individual ingredient amounts clearly disclosed without proprietary blends?

Ingredient Diversity36/100

Does the formula include a breadth of beneficial compounds from multiple pathways?

Strengths

  • +Product data available for comparison

Weaknesses

  • −Missing several expected ingredients for its category
  • −Proprietary blends hide individual ingredient amounts
  • −Limited ingredient diversity compared to category norms

Ingredient Analysis (1 ingredients)

IngredientAmountDose Adequacy
Proprietary Blend (Combination)—N/A

Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.